Instituto Nacional de Câncer José de Alencar Gomes da Silva - INCA

Rio de Janeiro, Rio de Janeiro 20231-050

0 studies enrolling now · 1 studies all time

What they study most

mCRPC

Studies at this site

• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling